IMV Inc IMVIF

Update on DPX-Covid19

[Breakthorough]

https://www.businesswire.com/news/home/20201228005059/en/

[8inchlynch]

This is the most press and most aggressive style promotion I've seen the company or ceo get in 19.5 years invested in IMV. Even got a mention on CNBC https://www.cnbc.com/2020/12/28/stocks-making-the-biggest-moves-premarket-alibaba-att-astrazeneca-doordash-others.html?__source=google%7Ceditorspicks%7C&par=google

[qwerty22]

So still at the preclinical phase with more to come, no immediate plan to go into humans. They talk about the "evolution of the regulatory landscape", it seems reasonable to think this is the main driver of the constantly revised timelines. I guess the one thing I'd like more detail on is the ferret challenge study, some way to compare the response in this vaccine to others just to

[FastFF]

This is the difference between socialized medicine and the US - while Health Canada may get around to doing something in the next decade, they are pumping out vaccine here. I say investors should forget about Covid for IMV and focus on the cancer drug. There's enough with cancer to drive the stock to multi billions over next year or 2. The simple fact is they used the virus to raise money at

[qwerty22]

The first approved was the UK, mother of all "socialized" medicine!!!    

[FastFF]

I didn't know Pfizer was a UK company? wow - I do, however, agree Oxford is a top notch research school. Unfortunately, the Canada best is a community college in Moosejaw. Anyway, thanks IMV for the pump yesterday, which I sold and now look to buy back cheaper.